BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 12-month price […]
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 12-month price […]
